Share and Follow

Researchers conducted an analysis of medical records from nearly 1,000 advanced cancer patients at MD Anderson Cancer Center. This study focused on comparing the outcomes of patients who received either the Pfizer or Moderna COVID-19 vaccine with those who had not been vaccinated.
The research team announced plans to launch a nationwide clinical trial to test this treatment strategy among lung cancer patients.
“Our ultimate aim is to provide effective treatment options for patients undergoing immune therapy, particularly those who currently have limited options,” the researchers stated.
Meanwhile, in Australia, The University of Queensland’s BASE mRNA facility is actively engaged in exploring mRNA cancer vaccines.
In Australia, the BASE mRNA facility at The University of Queensland is dedicated to researching mRNA cancer vaccines.









